Because high expression levels of miR-125b led to AI resistance and activation of the AKT/mTOR pathway in breast cancer cells and were also associated with poor prognosis among our cohort, we hypothesized that acquisition of deregulated miR-125b expression represents an alternative trick used by HR+ AI-resistant breast cancer cells to activate this crucial survival pathway. Here, MTOR is linked to breast carcinoma.